Eiger BioPharmaceuticals, Inc. 4
4 · Eiger BioPharmaceuticals, Inc. · Filed Mar 14, 2017
Insider Transaction Report
Form 4
Cory David A
DirectorPresident and CEO
Transactions
- Award
Stock Option (Right to Buy)
2017-03-09+133,000→ 133,000 totalExercise: $11.75Exp: 2027-03-09→ Common Stock (133,000 underlying)
Footnotes (1)
- [F1]The option vests in equal monthly installments over 48 months measured from March 9, 2017 subject to Reporting Person's continuous service status as of each such date.